ES8206855A1 - Detection of human cancer cells with antibodies to human cancer cell nucleolar antigen(s) - Google Patents
Detection of human cancer cells with antibodies to human cancer cell nucleolar antigen(s)Info
- Publication number
- ES8206855A1 ES8206855A1 ES498305A ES498305A ES8206855A1 ES 8206855 A1 ES8206855 A1 ES 8206855A1 ES 498305 A ES498305 A ES 498305A ES 498305 A ES498305 A ES 498305A ES 8206855 A1 ES8206855 A1 ES 8206855A1
- Authority
- ES
- Spain
- Prior art keywords
- human cancer
- antibodies
- nucleolar antigen
- cancer cells
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Detergent Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Specific nucleolar antigen(s) are found common to a broad range of human malignant tumor specimens and have been isolated, extracted and purified. Antibodies and antisera specific to these nucleolar antigen(s) are harvested from non-human hosts and used for detection of human cancer cells. Disclosed are (1) methods for isolating the nucleolar antigen(s), obtaining them in substantially purified form, producing the specific antibodies, obtaining them in substantially purified form, and using the antisera and antibodies induced by the nucleolar antigen(s) in diagnostic procedures for detecting human cancer cells, and (2) diagnostic kits comprising specific antibodies and antisera.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000343088A CA1157373A (en) | 1980-01-04 | 1980-01-04 | Detection of human cancer cells with antibodies to human cancer nucleolar antigen(s) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8206855A1 true ES8206855A1 (en) | 1982-08-01 |
| ES498305A0 ES498305A0 (en) | 1982-08-01 |
Family
ID=4115973
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES498305A Granted ES498305A0 (en) | 1980-01-04 | 1981-01-02 | A PROCEDURE FOR THE PREPARATION OF ANTIBODIES WITH SPECIALTY AGAINST ANTIGENS FOUND IN THE NUCLEUS AND NU-CLEOLOS OF CANCER HUMAN CELLS. |
| ES509239A Granted ES509239A0 (en) | 1980-01-04 | 1982-02-01 | A PROCEDURE TO DETECT THE LOCATION OF THE ANTIGEN-ANTIBODY REACTION PRODUCT IN THE MALIGNANT CELLS. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES509239A Granted ES509239A0 (en) | 1980-01-04 | 1982-02-01 | A PROCEDURE TO DETECT THE LOCATION OF THE ANTIGEN-ANTIBODY REACTION PRODUCT IN THE MALIGNANT CELLS. |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS56101553A (en) |
| KR (1) | KR850001770B1 (en) |
| AR (1) | AR232046A1 (en) |
| AT (1) | AT373397B (en) |
| AU (1) | AU535024B2 (en) |
| BE (1) | BE886935A (en) |
| CA (1) | CA1157373A (en) |
| CH (1) | CH659328A5 (en) |
| DE (1) | DE3047654A1 (en) |
| DK (1) | DK554980A (en) |
| ES (2) | ES498305A0 (en) |
| FI (1) | FI810007L (en) |
| FR (1) | FR2484650B1 (en) |
| GB (1) | GB2067286B (en) |
| GR (1) | GR72850B (en) |
| IE (1) | IE50760B1 (en) |
| IL (1) | IL61641A (en) |
| IT (1) | IT1172216B (en) |
| LU (1) | LU83015A1 (en) |
| NL (1) | NL8007128A (en) |
| NO (2) | NO803910L (en) |
| NZ (1) | NZ195756A (en) |
| OA (1) | OA06713A (en) |
| PH (5) | PH18765A (en) |
| PT (1) | PT72301B (en) |
| SE (1) | SE450665B (en) |
| ZA (1) | ZA807754B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4487830A (en) * | 1982-05-14 | 1984-12-11 | American Hoechst Corporation | Enzyme/immunofluorescent assay for autoantibodies |
| JPS5990052A (en) * | 1982-11-16 | 1984-05-24 | Katsu Taniguchi | Melanoma diagnosis medicine using monoclonal specific antibody |
| US4871661A (en) * | 1983-11-23 | 1989-10-03 | The Ohio State University Research Foundation | Process for testing the carcinogenicity of a material or the presence of cancer-inducing factors in an environment |
| US4746539A (en) * | 1983-11-23 | 1988-05-24 | The Ohio State University Research Foundation | Purification of cancer-associated protein and preparation of antibody thereto |
| EP0145373B1 (en) * | 1983-11-23 | 1992-03-25 | The Ohio State University Research Foundation | Purification of cancer-associated protein and preparation of antibody thereto |
| US4645737A (en) * | 1984-03-05 | 1987-02-24 | American Hoechst Corporation | Enzyme/immunofluorescent assay for anti-treponemal antibodies |
| US4607008A (en) * | 1984-03-05 | 1986-08-19 | American Hoechst Corporation | Enzyme/immunofluorescent assay for anti-Epstein-Barr Virus antibodies |
| DE3485740D1 (en) * | 1984-05-02 | 1992-06-25 | Univ Research Corp | IMMUNOLOGICAL TEST PROCEDURE FOR A PROCOAGULATING ENZYME FOR DETECTING CANCER. |
| US4616658A (en) * | 1985-02-27 | 1986-10-14 | William Shell | Non-radioactively labeled microspheres and use of same to measure blood flow |
| US4798719A (en) * | 1986-09-11 | 1989-01-17 | University Of Pittsburgh | Method for selection of antigens suitable as in vivo targets for antibodies |
| US4861581A (en) * | 1986-12-05 | 1989-08-29 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
| US5019368A (en) * | 1989-02-23 | 1991-05-28 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
| CA2023030A1 (en) * | 1990-07-13 | 1992-01-14 | Robert R. Guerrero | In vitro method and probe for detecting the presence of the ring shaped particle and malignancy in humans and animals |
-
1980
- 1980-01-04 CA CA000343088A patent/CA1157373A/en not_active Expired
- 1980-12-04 NZ NZ195756A patent/NZ195756A/en unknown
- 1980-12-04 AU AU65070/80A patent/AU535024B2/en not_active Ceased
- 1980-12-04 IE IE2533/80A patent/IE50760B1/en unknown
- 1980-12-05 IL IL61641A patent/IL61641A/en unknown
- 1980-12-10 ZA ZA00807754A patent/ZA807754B/en unknown
- 1980-12-15 PH PH24978A patent/PH18765A/en unknown
- 1980-12-17 DE DE19803047654 patent/DE3047654A1/en active Granted
- 1980-12-18 LU LU83015A patent/LU83015A1/en unknown
- 1980-12-22 AR AR283753A patent/AR232046A1/en active
- 1980-12-22 NO NO803910A patent/NO803910L/en unknown
- 1980-12-27 JP JP18948880A patent/JPS56101553A/en active Pending
- 1980-12-29 DK DK554980A patent/DK554980A/en not_active Application Discontinuation
- 1980-12-30 KR KR1019800005026A patent/KR850001770B1/en active
- 1980-12-30 CH CH9652/80A patent/CH659328A5/en not_active IP Right Cessation
- 1980-12-31 NL NL8007128A patent/NL8007128A/en not_active Application Discontinuation
- 1980-12-31 PT PT72301A patent/PT72301B/en unknown
- 1980-12-31 BE BE0/203378A patent/BE886935A/en not_active IP Right Cessation
- 1980-12-31 GB GB8041638A patent/GB2067286B/en not_active Expired
-
1981
- 1981-01-02 SE SE8100011A patent/SE450665B/en not_active IP Right Cessation
- 1981-01-02 FR FR8100014A patent/FR2484650B1/en not_active Expired
- 1981-01-02 ES ES498305A patent/ES498305A0/en active Granted
- 1981-01-02 FI FI810007A patent/FI810007L/en not_active Application Discontinuation
- 1981-01-05 IT IT67001/81A patent/IT1172216B/en active
- 1981-01-05 GR GR63789A patent/GR72850B/el unknown
- 1981-01-05 AT AT0001081A patent/AT373397B/en not_active IP Right Cessation
- 1981-01-05 OA OA57289A patent/OA06713A/en unknown
-
1982
- 1982-02-01 ES ES509239A patent/ES509239A0/en active Granted
-
1983
- 1983-02-21 PH PH28549A patent/PH18636A/en unknown
- 1983-02-21 PH PH28548A patent/PH18624A/en unknown
- 1983-02-21 PH PH28550A patent/PH18129A/en unknown
- 1983-02-21 PH PH28547A patent/PH18637A/en unknown
-
1985
- 1985-01-02 NO NO850005A patent/NO850005L/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8307377A1 (en) | Detection of human cancer cells with antibodies to human cancer cell nucleolar antigen(s) | |
| EP0284429A3 (en) | Antibodies to human cancer nucleolar antigen pl20, corresponding cell lines, and their preparation and use in the detection of human cancer cells | |
| FI803756L (en) | HYBRIDCELLINJE FOER FRAMSTAELLNING AV MONOCLONISK ANTIKROPP TILL TIDIG TYMOCYT ANTIGEN AV MAENNISKAN ANTIKROPP OCH METODER | |
| DE3789781T2 (en) | Antigens, antibodies and methods for identifying human metastatic tumors and cell lines for the production of these antibodies. | |
| DK314586A (en) | MONOCLONAL ANTIBODIES AND ANTIGENS FOR HUMAN LUNGCARCINOMES NON-SMALL CELL TYPE | |
| DE3069404D1 (en) | Radioimmunoassay of migration inhibitory factor | |
| EP0226468A3 (en) | Detection of human cancer cells with antibodies to human cancer nucleolar antigen p145 | |
| GB2176890B (en) | Monoclonal antibodies for human non-small cell lung carcinomas | |
| FR2482980B1 (en) | ||
| ES8802196A1 (en) | Monoclonal antibodies specific for human basal cell and malignant squamous cell protein, hybridomas therefor, malignancy test methods and diagnostic kits. | |
| JPS51146897A (en) | Method of determination of existence of malignant sickness by analyzing biological cell specimen | |
| EP0248147A3 (en) | Method of determining the presence of cancer cells | |
| DE2967143D1 (en) | Diagnostic method, especially for the early recognition of malignant tumors and/or viral diseases, and means to carry it out | |
| IL67944A0 (en) | Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same | |
| JPS5646819A (en) | Related carcinoembryonic antigen substance | |
| Lanfang et al. | The clinicopathologic characters and prognosis of cervical cancer in 831 young women under 35 years old | |
| KR780001034Y1 (en) | Transparency envelope of collecting specimen for album | |
| FR2327798A1 (en) | Astrocytin and malignin from tumour tissue - for prepn of products for cancer diagnosis and therapy |